CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Clinical trials for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL explained in plain language.
Never miss a new study
Get alerted when new CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL trials appear
Sign up with your email to follow new studies for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetic clue could guide heart drug use in Post-Heart attack patients
Disease control Not yet recruitingThis study is testing if a low-dose anti-inflammatory drug (colchicine) can slow the progression of coronary artery plaque in people who have recently had a heart attack. It specifically aims to see if the drug works better for patients who have a certain genetic marker called TE…
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Massive study launches to unravel mystery link between blood and immune system
Knowledge-focused Not yet recruitingThis study aims to understand how disorders in blood cell production are connected to various inflammatory and autoimmune diseases. Researchers will observe 5,000 adult patients who have these conditions, collecting their health information over time. The goal is to create a deta…
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC